BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6139277)

  • 1. Recurrent pheochromocytoma associated with glucagonoma. A case report.
    Yao H; Fukiyama K; Kawano Y; Mizumoto K; Toyoshima S; Omae T
    Endocrinol Jpn; 1983 Apr; 30(2):163-6. PubMed ID: 6139277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
    Tanaka K; Watabe T; Shimizu N; Horiuchi T; Nakamura K; Yoshida H
    Metabolism; 1984 Aug; 33(8):728-33. PubMed ID: 6087085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of glucagonoma].
    Numakawa T; Ikeuchi T; Sugimasa T; Inoue S; Takamura Y; Suda T
    Nihon Naika Gakkai Zasshi; 1982 Jul; 71(7):977-84. PubMed ID: 6294199
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glucagonoma syndrome with normal blood glucagon ].
    Quencez E; Zultak M; Blanc D; Gillet M; Laurent R
    Ann Dermatol Venereol; 1987; 114(9):1103-8. PubMed ID: 2829690
    [No Abstract]   [Full Text] [Related]  

  • 5. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
    Hendriks T; Jansen JB; van Tongeren JH
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glucagonoma and somatostatinoma].
    Yoshida H; Shimizu N
    Nihon Rinsho; 1982 Feb; 40(2):441-5. PubMed ID: 6283209
    [No Abstract]   [Full Text] [Related]  

  • 7. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
    Torre L; Vazquez JA; Blázquez E
    Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagonoma syndrome.
    Hashizume T; Kiryu H; Noda K; Kano T; Nakano R
    J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):377-83. PubMed ID: 2842381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glucagonoma syndrome with a normal blood glucose curve].
    González de Zárate Apiñariz P; Alonso Alonso J; Vázquez García JA; Hernández Calvo J; Burgos Bretones J; Aguirre Errasti C; Díaz Pérez JL
    Med Clin (Barc); 1983 Oct; 81(9):396-8. PubMed ID: 6316044
    [No Abstract]   [Full Text] [Related]  

  • 10. Pheochromocytoma with multiple islet cell carcinoma.
    Tamasawa N; Terada A; Kodama T; Ishigame M; Ishimaru K; Hishida R; Satoh T; Takebe K; Sasaki M; Imamura K
    Presse Med; 1994 Jan 8-15; 23(1):32-4. PubMed ID: 7907420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case report of malignant glucagonoma with a profile of immunoreactive glucagon before and after the operation].
    Ohtsuka K; Nimura Y; Takaesu H; Yokoi S; Shionoya S; Yasui K
    Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2223-6. PubMed ID: 3029475
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased "large glucagon-immunoreactivity".
    Recant L; Perrino PV; Bhathena SJ; Danforth DN; Lavine RL
    Diabetologia; 1976 Aug; 12(4):319-26. PubMed ID: 183997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent insulinoma syndrome with metastatic glucagonoma.
    Dunn PJ; Sheppard MC; Heath DA; Slaney G
    J Clin Pathol; 1983 Sep; 36(9):1076-80. PubMed ID: 6136529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y in multiple endocrine neoplasia: release during surgery for phaeochromocytoma.
    Connell JM; Corder R; Asbury J; Macpherson S; Inglis GC; Lowry P; Burt AD; Semple PF
    Clin Endocrinol (Oxf); 1987 Jan; 26(1):75-84. PubMed ID: 2879655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of bilateral pheochromocytoma and pancreatic islet cell tumor: report of a case and review of the literature.
    Tateishi R; Wada A; Ishiguro S; Ehara M; Sakamoto H; Miki T; Mori Y; Matsui Y; Ishikawa O
    Cancer; 1978 Dec; 42(6):2928-34. PubMed ID: 215301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case with glucagonoma syndrome--endocrine and metabolic studies.
    Fukushima H; Yamaguchi K; Uzawa H; Kitoh M; Takemiya M; Konno T
    Endocrinol Jpn; 1981 Apr; 28(2):111-25. PubMed ID: 6273136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucagonoma syndrome and its management.
    Kessinger A; Lemon HM; Foley JF
    J Surg Oncol; 1977; 9(5):419-24. PubMed ID: 201809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary prolactinoma, pancreatic glucagonomas, and aldosterone-producing adrenal cortical adenoma: a suggested variant of multiple endocrine neoplasia type I.
    Gould E; Albores-Saavedra J; Shuman J
    Hum Pathol; 1987 Dec; 18(12):1290-3. PubMed ID: 2824331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel changes of atrial natriuretic factor and catecholamines during surgery for pheochromocytoma.
    Donckier J; Michel L; Collard E; Berbinschi A; Ketelslegers JM; Harvengt C; Buysschaert M
    Am J Med; 1988 Aug; 85(2):278-9. PubMed ID: 2899974
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multiple endocrine neoplasia].
    Guan H; Zhu Y; Liu GZ
    Zhonghua Wai Ke Za Zhi; 1987 May; 25(5):287-9, 316-7. PubMed ID: 2890500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.